Aldeyra Therapeutics Statistics
NASDAQ: ALDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9586+0.0427 (+4.66%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Aldeyra Therapeutics by the numbers
Aldeyra Therapeutics has a market capitalization of $57.8 million based on 60.33M shares outstanding. With trailing EPS of $-0.38, Aldeyra Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.2% below its 50-day average and 63.6% below its 200-day average.
Average daily trading volume is 1.19M shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALDX valuation vs. peer median
| Metric | ALDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $57.83M | $58.57M | -1% |
| Avg. volume | 1.19M | 172.83K | +589% |
Peer median across 8 companies: ACET, XLO, MREO, CNTB, CLNN, BOLD, ATHE, ZYBT.
Valuation
- Market cap
- $57.83M
- EPS (TTM)
- $-0.38
- Shares outstanding
- 60.33M
Price and trading
- Previous close
- 0.9159
- Open
- 0.91
- Day range
- 0.8812 – 0.9666
- 52-week range
- 0.862 – 5.93
- 52-week change
- -82.91%
- Beta
- —
- Volume
- 1.28M
- Average volume
- 1.19M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 57.83M
- Forward Pe
- -3.49
- Eps
- -0.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.93
- Week52 Low
- 0.86
- Avg Volume
- 1.19M
- Shares Outstanding
- 60.33M
- Ma50
- 1.44
- Ma200
- 2.63
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -83.83%
- Pct From52w Low
- 11.21%